1. Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?

   • David M. Taylor

   Editorial 03 March 2017 Pages: 177 - 180

2. Binge Drinking: Current Diagnostic and Therapeutic Issues

   • Benjamin Rolland
   • Mickaël Naassila

   Current Opinion 15 February 2017 Pages: 181 - 186

3. Nogo-A Antibodies for Progressive Multiple Sclerosis

   • Benjamin V. Ineichen
   • Patricia S. Plattner
   • Martin E. Schwab

   Leading Article 19 January 2017 Pages: 187 - 198

   

4. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine

   • Leonie Hennissen
   • Mireille J. Bakker
   • The ADDUCE consortium

   Systematic Review Open access 24 February 2017 Pages: 199 - 215

   

5. Outcome Measures in Clinical Trials for Multiple Sclerosis

   • Caspar E. P. van Munster
   • Bernard M. J. Uitdehaag

   Review Article Open access 09 February 2017 Pages: 217 - 236

   

6. Impact of Drug Manipulation on Seizure Freedom in Adults with Uncontrolled Epilepsy: A Prospective Controlled Study in Rural China

   • Xiaoting Hao
   • Ziyi Chen
   • Dong Zhou

   Original Research Article 22 November 2016 Pages: 237 - 243

   

7. Benzodiazepine Use and Risk of Developing Alzheimer’s Disease: A Case-Control Study Based on Swiss Claims Data

   • Fabienne A. Biétry
   • Alena M. Pfeil
   • Christoph R. Meier

   Original Research Article 11 January 2017 Pages: 245 - 251